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Abstract
Introduction: The neurocognitive deficits associated with small cell lung cancer include metastasis
to brain and paraneoplastic syndrome. The patients are also predisposed to herpes encephalitis due
to immunosuppression and chemotherapy.
Case presentation: We report a case of 72 year old female diagnosed with small cell lung cancer
started with memory deficits, ataxia, vertigo, and hearing loss. The paraneoplastic work-up
returned as anti-Hu antibody positive. The MRI brain showed area of edema and inflammation right
medial temporal lobe as well as enhancement in the underlying meningi. Although PCR/HSV of CSF
was negative, the patient was empirically treated with IV acyclovir and showed significant
improvement and was discharged in good condition.
Conclusion: The case highlights the importance of keeping broad minded approach in treating
patients with serious malignant diseases. The case also call attention to the use of empiric therapy
in possible life threatening diseases such as Herpes encephalitis
Introduction
We report a case of 72 year old female diagnosed with
small cell lung cancer started with neurocognitive deficits
over the few weeks. The patient was empirically treated for
suspected herpes encephalitis on the basis of clinical and
MRI findings with acyclovir and showed significant
improvement.
Case presentation
In May 2008, 72 year old female was diagnosed of small
cell lung cancer incidentally after she was hospitalized for
anxiety and dizziness. She was hyponatremic and series of
tests which included a CT scan of the chest which showed
right hilar lymphadenopathy and mediastinal lymphade-
nopathy (Figure 1). She then had a mediastinoscopy
which was consistent with small cell lung cancer. PET/CT
scan findings were consistent with CT scan. She was staged
as limited stage small cell carcinoma of lung. She was
started treatment with etopside and carboplatin. In
July2008, after receiving two cycles of chemotherapy, she
presented with new onset memory difficulties.
Further work-up included a MRI of brain with and with-
out gadolinium as well as PET scan showed no evidence
of metastatic disease to the brain. These symptoms were
thought due to underlying anxiety or depression.
Few days later she started with ataxia, vertigo and hearing
loss. She was prescribed meclizine which provided no
relief. She then went to emergency department. At that
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Audiogram was done which revealed bilateral sen-
sorineural hearing loss greater on the left side. The parane-
oplastic workup was sent to rule out paraneoplastic
syndrome. The anti-Hu antibody came positive. The diag-
nosis of anti-Hu syndrome was entertained. She was
started on radiation therapy in addition to her chemother-
apy for consolidation. She received 3960 cGy of radiation
to the mediastinum in August 2008.
Three weeks later, she began developing loss of smell sen-
sation to the point that she was completely anosmic. Her
unsteadiness reached to the point that she needed assist-
ance for walking short distance. MRI of brain showed new
area of edema and inflammation in the right medial tem-
poral lobe as well as enhancement in the underlying men-
ingi (Figure 2). She was admitted for to the hospital for
empiric IV acyclovir therapy for possible herpes encepha-
litis. The Lumber puncture was done which showed
increased proteins (Total proteins 5.7 g/l, Beta globulin of
0.73 g/l) and lymphocytes. The CSF HSV/PCR was nega-
tive. Patient was discharged in the 6 th day from the hos-
pital and received total 10 days of IV acyclovir as she
improved on the treatment. Patient is now planned for
further chemoradiation therapy.
The neurocognitive deficits in our patient were probably
because of either anti-Hu syndrome or Herpes encephali-
tis.
The anti HU syndrome is a neurologic paraneoplastic syn-
drome. A specific anti body called anti HU is present in
serum and CSF of these patients [1]. Patients with anti-Hu
antibodies usually have SCLC (94%), multifocal neuro-
logical symptoms and a poor prognosis [2]. Anti-Hu
encephalomyelitis is one of the most frequent paraneo-
plastic syndromes, classically presenting with diffuse neu-
rological involvement [3]. Anti-Hu antibodies are present
in about 50% of patients with limbic encephalitis and
lung cancer and is characterized by marked reduction in
short term memory and sub acute confusion. Many
patients may also develop rapid pancerebellar dysfunc-
tion due to extensive purkinjee neuronal loss termed as
sub acute cerebellar ataxia. The HU-Abs is reported to be
present in about 23% of these patients. The Anti-Hu anti-
bodies, in addition to SCLC are associated with prostate
cancer and neuroblastoma [4].
Anti-HU antibodies are also associated with Encephalo-
myelitis, sensory neuropathy, and autonomic neuropa-
thy. The limbic encephalitis and sub acute cerebellar
degeneration are associated relatively often with cancer
and are called "classical" PNS [5]. The treatment of PNS is
control of the tumor. Antitumor treatment has established
to stop paraneoplastic neurological deterioration. How-
ever, in debilitated patients treatment of underlying
tumor is withheld because of the little chance of clinically
relevant neurological improvement [5].
CT scan showing right hilar lymphadenopathyFigure 1
CT scan showing right hilar lymphadenopathy.
MRI showing abnormal signal intensity involving the medial aspect f the right temporal lobeFigure 2
MRI showing abnormal signal intensity involving the 
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Herpes simplex encephalitis patients may have a pro-
drome of malaise, fever, headache, and nausea that is fol-
lowed by acute or sub acute onset of an encephalopathy
whose symptoms include lethargy, Confusion, and delir-
ium. Patients may also have seizures, aphasia, and other
focal neurological deficits. The herpes encephalitis is fatal
in 7 to 14 days if not treated and mortality as high as 70%
in untreated cases. Neurology consultation should be
sought as HSV encephalitis is neurologic emergency and
treatment should be started with acyclovir in suspicious
cases or when diagnosis is established. [6] In our case, the
patient developed anosmia and that can be present in
65% of patients of HSV encephalitis [7]. However, PCR of
spinal fluid for HSV was negative. PCR itself has a
reported sensitivity of 98% and a specificity of 94% for the
detection of HSV in the CSF [8].
False negative results may occur: [9]
1. Occasionally in bloody specimens through inhibition
of PCR
2. When CSF has been obtained after starting Acyclovir.
3. When lumbar puncture has been performed early in
disease.
4. When lumbar puncture was delayed approximately 10
days or more into the disease process
Since a negative HSV PCR result does not entirely rule out
the possibility of HSE, an intrathecal antibody response
specific to HSV should also be sought [9].
Although we did not prove the agent microbiologically
but the MRI changes and Clinical improvement, elevated
proteins and lymphocytes in CSF points towards HSV
encephalitis. Our next step is try to get diagnosis retro-
spectively by measuring serial serum and CSF titers
although it has no role in acute diagnosis and treatment
[10].
Conclusion
The case emphasizes the diagnostic challenge the patients
with small cell lung cancer may present and clinicians
may end up treating patients empirically for suspected
infectious pathology. The case also demonstrates the need
to use empiric therapy in suspected life threatening dis-
eases such as Herpes encephalitis.
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